MICS+aspheric IOL = fewer corneal changes

Article

Microincision cataract surgery (MICS) with implantation of an aspheric intraocular lens (IOL) through a 1.8 mm incision can minimize surgically-induced corneal and ocular aberrations and improve optical performance, according to a French study.

Microincision cataract surgery (MICS) with implantation of an aspheric intraocular lens (IOL) through a 1.8 mm incision can minimize surgically-induced corneal and ocular aberrations and improve optical performance, according to a French study.

Alexandre Denoyer and co-workers from Bretonneau University Hospital, France evaluated the postoperative corneal and ocular aberrations of 20 subjects following MICS with implantation of the aspheric MI60 IOL (Bausch & Lomb) through a 1.8 mm incision in one eye and through a 2.8 mm incision in the other eye.

The researchers found that changes in the corneal topography and aberrations were lower in the MICS group than in the other eye (p<0.05), as were the total ocular wavefront aberrations (p<0.05). Best corrected visual acuity and subjective visual comfort were similar in both groups.

Dr Denoyer concluded that MICS with implantation of an aspheric IOL can help minimize surgically-induced corneal changes.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.